F Dx Advisors, Inc. Immuno Gen, Inc. Transaction History

F Dx Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	BUY	$2.12 - $6.8 $73,797 - $236,708	34,810 New	34,810 $1.88 Million
Q4 2019 Feb 12, 2020	SELL	$2.25 - $5.8 $26,181 - $67,488	-11,636 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$2.22 - $3.39 $279 - $427	126 Added 1.09%	11,636 $28,000
Q2 2019 Jul 19, 2019	BUY	$1.8 - $3.3 $20,718 - $37,983	11,510 New	11,510 $25,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.